Coronavirus (COVID-19)
National and International Guidance Documents
Public Health Agency of Canada CORONAVIRUS HOTLINE 1-833-784-4397
Canadian and International guidelines, policies and standards that Infection Prevention and Control professionals may use to support their own documentation and best practices during the COVID-19 Pandemic.
Quick Index
- Government of Canada
- Guidance in Healthcare Settings
- COVID-19 Guidance During Pregnancy
- Laboratory and Supply Chain Guidance
- Guidance on Personal Protective Equipment and Alcohol-Based Hand Sanitizer
- Vaccine Guidance
- Public Health Guidance
- School and Community Guidance
- Awareness Resources
- Alerts, Recalls and Advisories
- CDC
- WHO
- APIC
- Other
Government of Canada
- COVID-19 Resources and Checklists (PHAC, Accreditation Canada and HSO)
- Interim national case definition: Coronavirus disease (COVID-19)
- Outbreak Update
- Update on COVID-19 in Canada: Epidemiology and modelling
- COVID-10 Symptoms and Treatments
- COVID-19 signs, symptoms and severity of disease: A clinician guide
- COVID-19: Main modes of transmission
- COVID-19 Prevention and risks
- Coronavirus disease (COVID-19): Canada’s Response
- Coronavirus disease (COVID-19): Travel restrictions, exemptions and advice
- Chief Public Health Officer of Canada's Report on the State of Public Health in Canada 2020 -From risk to resilience: An equity approach to COVID-19
- Race-Based Data Collection and Health Reporting
COVID-19 Guidance in Healthcare Settings
- COVID-19 Pandemic Guidance for the Health Care Sector
- COVID-19 for Health Professionals
- Pan-Canadian COVID-19 Testing and Screening Guidance: Technical guidance and implementation plan
- Routine practices and additional precautions for preventing the transmission of infection in healthcare settings
- Clinical management of patients with moderate to severe COVID-19: Interim guidance
- Infection prevention and control for novel coronavirus (COVID-19): Interim guidance for acute healthcare settings
- Infection prevention and control for COVID-19: Interim guidance for outpatient and ambulatory care settings
COVID-19 Guidance During Pregnancy
- Statement on Pregnant Workers during the COVID-19 Pandemic (SOGC)
- COVID-19 and Pregnancy (SOGC)
- Statement on COVID-19 Vaccination in Pregnancy (SOGC)
Laboratory and Supply Chain Guidance during the COVID-19 Pandemic
COVID-19 Guidance on Personal Protective Equipment (PPE) and Alcohol-Based Hand Sanitizer (ABHR)
- Non-medical Masks and Face Coverings
- Non-medical Masks -How to put on, remove and clean
- Non-medical Masks -Sew and no-sew instructions
- Use of Non-Medical Masks in Community Settings
- Non-medical masks or face coverings while travelling on public transportation
- How to safely use a non-medical mask or face covering (poster)
- How to wear a non-medical mask or face covering properly (video)
Vaccine Guidance
COVID-19 Awareness Resources
-
Coronavirus disease (COVID-19): Awareness resources (Posters and Videos)
-
Coronavirus disease (COVID-19): Information sheet - Travellers returning to Canada (includes contact information for public health authorities in each province and territory)
- Novel Coronavirus infection: Frequently Asked Questions (FAQ)
- People who are at risk of more severe disease or outcomes from COVID-19
- COVID-19 antibody (serology) testing: Information for patients
- COVID-19: We're doing this for this (closed captions in other languages)
- COVID-19: How vaccines are developed
- Vaccine development and approval in Canada
- People who are at risk of more severe disease or outcomes from COVID-19
Alerts, Recalls and Advisories
- Jan 22: Hand sanitizers labelled as "Anti-Microbe" and/or with DIN 02248351 recalled because they may pose health risks, particularly to children
- Dec 23: Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels
- Dec 22: Personal protective equipment sold by Maskopia (formerly Medkem Canada Inc.) may pose serious health risks
- Dec 16: Health Canada warns Canadians not to buy COVID-19 vaccines sold online or from unauthorized sources
- Dec 12: Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
- Dec 11: Recall of certain hand sanitizers that may pose health risks
- Nov 18: Ultraviolet (UV) lights and wands falsely claiming to disinfect against COVID-19
- Nov 13: Recall of certain hand sanitizers that may pose health risks
- Nov 2: Recall of certain hand sanitizers that may pose health risks
- Oct 28: Recall of Daily Shield Hand Sanitizers across Canada
- Oct 19: Recall of certain hand sanitizers that may pose health risks
- Oct 18: Counterfeit Daily Shield Hand Sanitizer
- Oct 13: Recall of certain hand sanitizers that may pose health risks
- Sep 28: Recall of certain hand sanitizers that may pose health risks
- Sept 15: Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
- Sept 14: Recall of certain hand sanitizers that may pose health risks
- Sep 4: Advisory on hand sanitizers and children’s safety: What you need to know
- Sep 4: Recall of certain hand sanitizers that may pose health risks
- Aug 21: Recall of certain hand sanitizers that contain technical-grade ethanol
- Aug 4: Recall of certain hand sanitizers that may pose health risks
- Jul 28: Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
- Jul 21: Recall of certain hand sanitizers that may pose health risks
- Jul 6: Counterfeit respirators
- Jun 30: Recall of certain hand sanitizers that may pose health risks
- Jun 24: Recall of certain hand sanitizers that contain technical-grade ethanol
- Jun 10: Risk of poisoning from hand sanitizers sold in beverage containers
- Jun 6: Recall of certain hand sanitizers that may pose health risks
- Jun 1: Health Canada advises Canadians to help support the continued supply of medications
- May 27: Consumers advised to stop using Akwaton International Multipurpose Wipes
- May 27: Some units of Triton Hand Sanitizer containing technical-grade ethanol sold in Canada without the necessary risk information
- May 25: Importation of US-Labelled Rocuronium Bromide Injection distributed by Avir Pharma Inc. Due to Shortage of Canadian-labelled Rocuronium
- May 19: Importation of Fresenius Propoven 2% due to Shortage of Canadian Labelled Propofol Injection 1% Products
- May 19: Importation of Spanish-Labelled Salbutamol Aldo-Union inhalers due to Shortage of Canadian-Labelled Salbutamol
- May 13: Important Safety Information - Importation of Teva UK-labelled Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage
- May 11: Important safety information for certain respirator masks
- May 7: Unauthorized test kits claiming to diagnose or detect COVID-19 put your health at risk
- May 6: Importation of US-Labelled Ketamine Hydrochloride for Injection due to Potential Shortage of Canadian-labelled Ketamine
- May 1: Clinical trial looking at the potential use of convalescent plasma to treat COVID-19
- Apr 25: Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician
- Apr 17: Shortage of salbutamol inhalers in Canada
- Apr 15: Health Canada is temporarily authorizing the use of technical-grade ethanol in hand sanitizer products: Always follow the label directions when using alcohol-based hand sanitizers
- Apr 14: Fraudulent and unauthorized N95 respirators may not protect consumers against COVID-19
Centers for Disease Control and Prevention
- CDC - Coronavirus COVID-19
- How COVID-19 Spreads
- Information for Healthcare Professionals about Coronavirus (COVID-19)
- Infection Control Guidance for Healthcare Professionals about Coronavirus (COVID-19)
- Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for 2019 Novel Coronavirus (COVID-19) in a Healthcare Setting
- CDC Situation Summary
- Interim Guidance for Public Health Personnel Evaluating Persons Under Investigation (PUIs) and Asymptomatic Close Contacts of Confirmed Cases at Their Home or Non-Home Residential Settings
- Interim Guidance for Collection and Submission of Postmortem Specimens from Deceased Persons Under Investigation (PUI) for COVID-19, February 2020
- Evaluating and Reporting Persons Under Investigation (PUI)
- Strategies for Optimizing the Supply of PPE
- Release of Stockpiled N95 Filtering Facepiece Respirators Beyond the Manufacturer-Designated Shelf Life: Considerations for the COVID-19 Response
- Decontamination and Reuse of Filtering Facepiece Respirators using Contingency and Crisis Capacity Strategies
- Healthcare Infection Control Guidance
- Healthcare Personnel with Potential Exposure Guidance
- Inpatient Obstetric Healthcare Guidance
- Clinical Care Guidance
- Nursing Homes and Long-Term Care Facilities (CDC)
- Home Care Guidance
- Considerations for Alternate Care Sites
- Guidance for EMS
- Guidance for Dental Settings (CDC)
- Collection and Submission of Postmortem Specimens from Deceased Persons with Known or Suspected COVID-19, March 2020 (Interim Guidance)
- Use of Cloth Face Coverings to Help Slow the Spread of COVID -19
- Options to Reduce Quarantine for Contacts of Persons with SARS-CoV-2 Infection Using Symptom Monitoring and Diagnostic Testing
World Health Organization/Organisation mondiale de la santé
- WHO -Coronavirus COVID-19 Outbreak
- COVID-19 Global Cases (WHO)
- Transmission of SARS-CoV-2: implications for infection prevention precautions
- WHO Online Course: Infection Prevention and Control (IPC) for Novel Coronavirus (COVID-19)
- WHO Rational use of personal protective equipment for coronavirus disease (COVID-19)
- Coronavirus disease (COVID-19) technical guidance: Infection prevention and control
- Criteria for releasing COVID-19 patients from isolation
- WHO Rational use of personal protective equipment for coronavirus disease (COVID-19)
- Novel coronavirus (COVID-19) Video
- Situation Reports
- Outbreak News
- WHO Disease Outbreak News (Jan 21/20)
Association for Professionals in Infection Control and Epidemiology
European Centre for Disease Control
- Algorithm for management of contacts of probable or confirmed COVID-19 cases
- Advice to healthcare workers: management of patients with COVID-19 infection
- Advice for travellers: outbreak of a novel coronavirus COVID-19
- Risk assessment: outbreak of acute respiratory syndrome associated with a novel coronavirus
Other Guidelines
- COVID-19 Resources (Canadian Nurses Association)
- COVID-19 Recommendations (Choosing Wisely)
- COVID-19: Recommendations for School Reopening (Sick Kids)
- Briefing Note on Addressing Mental Health and Psychosocial Aspects of COVID-19 Outbreak (United Nations Office for the Coordination of Humanitarian Affairs)
- National Interim Guidelines for Funeral Directors on managing infection risks when handling deceased individuals with confirmed COVID-19 (Health Protection and Surveillance Centre)
- ASHRAE Position Document on Infectious Aerosols (ASHRAE)
- Policy Guidance for the Reintegration of Caregivers as Essential Care Partners (CFHI & CPSI)
- Statement on COVID-19 Vaccination in Pregnancy (SOGC)
- Statement on Pregnant Workers during the COVID-19 Pandemic (SOGC)
- COVID-19 and Pregnancy (SOGC)
Dentistry
- Evidence to support safe return to clinical practice by oral health professionals in Canada during the COVID-19 pandemic: A report prepared for the Office of the Chief Dental Officer of Canada (PHAC)
- COVID-19 (Canadian Dental Association)
- COVID-19 (Canadian Dental Hygienists Association)
- COVID-19: Managing Infection Risks During In-Person Dental Care (Royal College of Dental Surgeons of Ontario)
- COVID-19: Guidance for the Use of Teledentistry (Royal College of Dental Surgeons of Ontario)
- COVID-19: Guidance on Returning to Dental Hygiene Practice (College of Dental Hygenists of Ontario)
- COVID-19 Recommendations (Canadian Dental Assistants Association)
- Recommendations for Dental Hygienists and Canadian Dental Assistants During COVID-19 Outbreak (Canadian Dental Assistants Association)
- Transitioning Oral Healthcare to Phase 2 of the COVID-19 Response Plan (BC College of Dental Surgeons/College of Dental Hygienists of BC)
- Expectations and Pathway for Patient Care during the COVID-19 Pandemic (Alberta Dental Association & College)
- Interim IPC Guidelines Related to COVID-19 Management (Manitoba Dental Association
- COVID-19 Operational Plan for the Practice of Dentistry in the Province of New Brunswick (New Brunswick Dental Association
- Pandemic Plan COVID-19 For Emergency and Urgent Care (Newfoundland and Labrador Dental Association)
- COVID-19: Managing Infection Risks During In-Person Dental Care (Royal College of Dental Surgeons of Ontario)
- COVID-19 Pandemic: Level 2 IPC Interim Protocol Update (Saskatchewan College of Dental Surgeons)
- Guidance for Dental Settings (CDC)
Prevention & Management of Skin Damage Related to PPE (NSWOCC and CNA)
- Prevention & Management of Skin Damage Related to Personal Protective Equipment (PPE)
- Best practice recommendation document
- Quick Reference Enabler
- Educational video
- Teaching powerpoint